Times-Standard on MSN
HCSO announces new program to address opioid crisis
Beginning this October, HCSO’s program “will provide Sublocade, a long-acting monthly injection designed to support ...
LONDON (Alliance News) - Indivior PLC on Monday said analysis of its Sublocade slow-release injectable found the drug could be more effective as an addition treatment at a higher dose. In a post-hoc ...
The CEO highlighted that 2024 ended with SUBLOCADE achieving 20% net revenue growth despite challenges, including competition in the U.S. long-acting injectable (LAI) market and the discontinuation of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback